Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma

C. K. Kim, J. T. Kim, H. Kang, Young Yoo, Y. Y. Koh

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: A significant proportion of patients diagnosed with cough-variant asthma eventually manifest classic asthma signs, such as wheezing and dyspnoea. The aim of this study was to investigate whether the percentage of eosinophils and/or concentration of eosinophilic cationic protein (ECP) in sputum induced from patients with cough-variant asthma can predict the development of classic asthma. Methods: Sixty-two children with cough-variant asthma were prospectively studied for 4 years. At the initiation of the study, sputum was induced with hypertonic saline, and the sputum samples were analysed for total and differential cell counts, and for ECP. Each subject was checked clinically at least every 3 months, and details of classic asthma signs experienced during the intervening periods were taken. Results: Twenty-four (47.1%) of the 51 subjects available for follow-up developed signs of classic asthma, while 27 did not. The only significant difference in the sputum parameters between these two groups was a higher percentage of sputum eosinophils in subjects who developed classic asthma. A significant association was found between sputum eosinophil percentage and classic asthma development, but not between the concentration of sputum ECP and classic asthma development. Conclusion: Sputum eosinophilia in cough-variant asthma may be a correlate of the later development of classic asthma. This suggests that sputum differential cell counts may be useful in the clinical management of patients with cough-variant asthma, as they may enable the prediction of the subsequent classic asthma development.

Original languageEnglish
Pages (from-to)1409-1414
Number of pages6
JournalClinical and Experimental Allergy
Volume33
Issue number10
DOIs
Publication statusPublished - 2003 Oct 1
Externally publishedYes

Fingerprint

Eosinophilia
Sputum
Cough
Asthma
Eosinophils
Cell Count
Proteins
Respiratory Sounds
Dyspnea

Keywords

  • Classic asthma
  • Cough-variant asthma
  • ECP
  • Eosinophil
  • Induced sputum

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. / Kim, C. K.; Kim, J. T.; Kang, H.; Yoo, Young; Koh, Y. Y.

In: Clinical and Experimental Allergy, Vol. 33, No. 10, 01.10.2003, p. 1409-1414.

Research output: Contribution to journalArticle

@article{5c5b4d41185a4ff886c2445cce90a5ee,
title = "Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma",
abstract = "Background: A significant proportion of patients diagnosed with cough-variant asthma eventually manifest classic asthma signs, such as wheezing and dyspnoea. The aim of this study was to investigate whether the percentage of eosinophils and/or concentration of eosinophilic cationic protein (ECP) in sputum induced from patients with cough-variant asthma can predict the development of classic asthma. Methods: Sixty-two children with cough-variant asthma were prospectively studied for 4 years. At the initiation of the study, sputum was induced with hypertonic saline, and the sputum samples were analysed for total and differential cell counts, and for ECP. Each subject was checked clinically at least every 3 months, and details of classic asthma signs experienced during the intervening periods were taken. Results: Twenty-four (47.1{\%}) of the 51 subjects available for follow-up developed signs of classic asthma, while 27 did not. The only significant difference in the sputum parameters between these two groups was a higher percentage of sputum eosinophils in subjects who developed classic asthma. A significant association was found between sputum eosinophil percentage and classic asthma development, but not between the concentration of sputum ECP and classic asthma development. Conclusion: Sputum eosinophilia in cough-variant asthma may be a correlate of the later development of classic asthma. This suggests that sputum differential cell counts may be useful in the clinical management of patients with cough-variant asthma, as they may enable the prediction of the subsequent classic asthma development.",
keywords = "Classic asthma, Cough-variant asthma, ECP, Eosinophil, Induced sputum",
author = "Kim, {C. K.} and Kim, {J. T.} and H. Kang and Young Yoo and Koh, {Y. Y.}",
year = "2003",
month = "10",
day = "1",
doi = "10.1046/j.1365-2222.2003.01788.x",
language = "English",
volume = "33",
pages = "1409--1414",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma

AU - Kim, C. K.

AU - Kim, J. T.

AU - Kang, H.

AU - Yoo, Young

AU - Koh, Y. Y.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Background: A significant proportion of patients diagnosed with cough-variant asthma eventually manifest classic asthma signs, such as wheezing and dyspnoea. The aim of this study was to investigate whether the percentage of eosinophils and/or concentration of eosinophilic cationic protein (ECP) in sputum induced from patients with cough-variant asthma can predict the development of classic asthma. Methods: Sixty-two children with cough-variant asthma were prospectively studied for 4 years. At the initiation of the study, sputum was induced with hypertonic saline, and the sputum samples were analysed for total and differential cell counts, and for ECP. Each subject was checked clinically at least every 3 months, and details of classic asthma signs experienced during the intervening periods were taken. Results: Twenty-four (47.1%) of the 51 subjects available for follow-up developed signs of classic asthma, while 27 did not. The only significant difference in the sputum parameters between these two groups was a higher percentage of sputum eosinophils in subjects who developed classic asthma. A significant association was found between sputum eosinophil percentage and classic asthma development, but not between the concentration of sputum ECP and classic asthma development. Conclusion: Sputum eosinophilia in cough-variant asthma may be a correlate of the later development of classic asthma. This suggests that sputum differential cell counts may be useful in the clinical management of patients with cough-variant asthma, as they may enable the prediction of the subsequent classic asthma development.

AB - Background: A significant proportion of patients diagnosed with cough-variant asthma eventually manifest classic asthma signs, such as wheezing and dyspnoea. The aim of this study was to investigate whether the percentage of eosinophils and/or concentration of eosinophilic cationic protein (ECP) in sputum induced from patients with cough-variant asthma can predict the development of classic asthma. Methods: Sixty-two children with cough-variant asthma were prospectively studied for 4 years. At the initiation of the study, sputum was induced with hypertonic saline, and the sputum samples were analysed for total and differential cell counts, and for ECP. Each subject was checked clinically at least every 3 months, and details of classic asthma signs experienced during the intervening periods were taken. Results: Twenty-four (47.1%) of the 51 subjects available for follow-up developed signs of classic asthma, while 27 did not. The only significant difference in the sputum parameters between these two groups was a higher percentage of sputum eosinophils in subjects who developed classic asthma. A significant association was found between sputum eosinophil percentage and classic asthma development, but not between the concentration of sputum ECP and classic asthma development. Conclusion: Sputum eosinophilia in cough-variant asthma may be a correlate of the later development of classic asthma. This suggests that sputum differential cell counts may be useful in the clinical management of patients with cough-variant asthma, as they may enable the prediction of the subsequent classic asthma development.

KW - Classic asthma

KW - Cough-variant asthma

KW - ECP

KW - Eosinophil

KW - Induced sputum

UR - http://www.scopus.com/inward/record.url?scp=0142042434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142042434&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2222.2003.01788.x

DO - 10.1046/j.1365-2222.2003.01788.x

M3 - Article

VL - 33

SP - 1409

EP - 1414

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 10

ER -